Validation of Preoperative Risk Grouping of the Selection of Patients Most Likely to Benefit From Neoadjuvant Chemotherapy Before Radical Cystectomy
Published inClinical genitourinary cancer, vol. 15, no. 2, p. e267-e273
Publication date2017
Abstract
Keywords
- Bladder cancer
- Muscle invasive bladder cancer
- Neoadjuvant chemotherapy
- Preoperative characteristics
- Radical cystectomy
Affiliation
Research group
Citation (ISO format)
MOSCHINI, Marco et al. Validation of Preoperative Risk Grouping of the Selection of Patients Most Likely to Benefit From Neoadjuvant Chemotherapy Before Radical Cystectomy. In: Clinical genitourinary cancer, 2017, vol. 15, n° 2, p. e267–e273. doi: 10.1016/j.clgc.2016.07.014
Main files (1)
Article (Published version)
Identifiers
- PID : unige:93724
- DOI : 10.1016/j.clgc.2016.07.014
- PMID : 27530435
ISSN of the journal1558-7673
